Profile
David Caouette is currently the Vice President-Corporate Communications at Seagen Inc. He previously worked as the Head-Media Relations at Merck & Co., Inc. and Biogen, Inc.
David Caouette active positions
| Companies | Position | Start |
|---|---|---|
| SEAGEN INC. | Public Communications Contact | 2021-05-31 |
Former positions of David Caouette
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Public Communications Contact | 2021-04-30 |
| MERCK & CO., INC. | Public Communications Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- David Caouette